Nel ASA's Revenue Conundrum Tests Investor Patience

Nel's pivotal AGM and Q1 results will test its strategic Samsung alliance and ability to turn a record hydrogen order into revenue, despite declining sales and a 'Moderate Sell' rating.

Nel ASA, the Norwegian hydrogen technology firm, finds itself at a critical juncture. Despite securing its largest-ever order just months ago, the company's financial statements continue to tell a story of declining sales, setting the stage for a pivotal fortnight of corporate events that will test investor confidence.

The immediate focus is a digital-only Annual General Meeting scheduled for April 10. A key item on the agenda is the renewal of the supervisory board mandate for Gyuyeon Kang, who represents Samsung E&A. The South Korean industrial giant is Nel's largest institutional shareholder with a 9.09% stake, stemming from a $33 million investment in March 2025 that established Nel as its preferred global hydrogen partner. The vote is seen as a barometer for the health of this strategic alliance.

This shareholder gathering occurs against a backdrop of stark financial figures. For Q4 2025, Nel reported revenues of 330 million Norwegian Kroner, a 20% year-on-year decline. Its EBITDA remained negative at -36 million NOK, showing little improvement in recent quarters. This performance gap is glaring when contrasted with the company's announcement of a record 40-megawatt PEM electrolyzer order from HYDS at the end of last year.

Market analysts are unified in their caution. The consensus rating sits at "Moderate Sell" with an average 12-month price target of approximately 2.14 Norwegian Kroner. Berenberg recently cut its target from 2.60 to 2.30 NOK, maintaining a "Hold" rating, while Citi also reduced its target to 2.40 NOK. Experts cite unproven market acceptance for new technology and the persistent challenge of converting a strong order book into tangible revenue. On the Oslo exchange, the share price has underperformed the FTSE Global All Cap Index by nearly 9.5% since October 2025.

The company is betting its future on a significant technological shift. In a strategic move, Nel took a 799 million NOK impairment charge on older production assets in Q4 2025, clearing the way for new platforms. A pressurized alkaline electrolyzer platform is slated for commercial launch in May 2026, with its development at the Herøya facility supported by potential EU Innovation Fund grants of up to 135 million euros. This new technology promises a 60% reduction in costs and a significantly smaller footprint. Simultaneously, production capacity at its U.S. plant in Connecticut is set to expand to 500 MW this year.

All eyes now turn to April 22, when Nel will break its current "Quiet Period" and release its Q1 2026 results. This report is anticipated to deliver the first concrete evidence of whether the company's record order and substantial technological investments are finally translating into the revenue growth shareholders have been awaiting. The coming weeks will determine if Nel can close the troubling gap between its promising backlog and its bottom line.